When extracellular cGMP and basal calcium concentrations are low (as in hyperammonemia) increasing extracellular cGMP reduces phosphorylation of CaMKII, increasing NOS activity, the function of the glutamate-NO-cGMP pathway and learning ability. The gene discussed is CAMK2G; the disease is Hyperammonemia.